Use of propylene glycol-free melphalan conditioning in light-chain amyloidosis patients undergoing autologous hematopoietic cell transplantation is well tolerated and effective

被引:0
|
作者
Talha Badar
Parameswaran Hari
Saurabh Chhabra
Binod Dhakal
William R. Drobyski
Timothy S. Fenske
Mehdi Hamadani
Marcelo Pasquini
Wael Saber
Nirav N. Shah
Bronwen E. Shaw
Anita D’Souza
机构
[1] Medical College of Wisconsin,Department of Medicine, Division of Hematology/Oncology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1210 / 1213
页数:3
相关论文
共 50 条
  • [21] Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis
    Kamble, Rammurti T.
    Obi, Gloria
    Scholoff, Audrey
    Carrum, George
    Rice, Lawrence
    Bhimrajan, Arvind
    Estep, Jerry
    [J]. BLOOD, 2015, 126 (23)
  • [22] ORTHOTOPIC HEART TRANSPLANT FACILITATED AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN LIGHT-CHAIN AMYLOIDOSIS
    Kamble, R. T.
    Carrum, G.
    Rice, L.
    McCarthy, J.
    Baker, K.
    Ramos, C. A.
    Adrogue, H.
    Estep, J. D.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S255 - S256
  • [23] Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
    Gonzalo Gutiérrez-García
    María Teresa Cibeira
    Montserrat Rovira
    Carlos Fernández de Larrea
    Natalia Tovar
    Luis Gerardo Rodríguez-Lobato
    Laura Rosiñol
    Pedro Marín
    Julio Solano-Vega
    María Suárez-Lledó
    Alex Bataller
    María Teresa Solano
    Noemí de Llobet
    Ariadna Domenech
    Nuria Borràs
    Miquel Lozano
    Joan Cid
    Carmen Martínez
    Álvaro Urbano-Ispizua
    Jordi Esteve
    Enric Carreras
    Francesc Fernández-Avilés
    Joan Bladé
    [J]. Bone Marrow Transplantation, 2019, 54 : 1295 - 1303
  • [24] Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis
    Gutierrez-Garcia, Gonzalo
    Teresa Cibeira, Maria
    Rovira, Montserrat
    Fernandez de Larrea, Carlos
    Tovar, Natalia
    Gerardo Rodriguez-Lobato, Luis
    Rosinol, Laura
    Marin, Pedro
    Solano-Vega, Julio
    Suarez-Lledo, Maria
    Bataller, Alex
    Teresa Solano, Maria
    de Llobet, Noemi
    Domenech, Ariadna
    Borras, Nuria
    Lozano, Miquel
    Cid, Joan
    Martinez, Carmen
    Urbano-Ispizua, Alvaro
    Esteve, Jordi
    Carreras, Enric
    Fernandez-Aviles, Francesc
    Blade, Joan
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 (08) : 1295 - 1303
  • [25] Modified High Dose Versus High Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis
    Edwards, Camille V.
    Brauneis, Dina
    Quillen, Karen
    Sanchorawala, Vaishali
    [J]. BLOOD, 2020, 136
  • [26] Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation
    Cowan, Andrew J.
    Klippel, Zandra K.
    Stevenson, Philip A.
    Hyun, Teresa S.
    Tuazon, Sherilyn
    Becker, Pamela S.
    Green, Damian J.
    Holmberg, Leona A.
    Coffey, David G.
    Gopal, Ajay K.
    Libby, Edward N.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (04): : 254 - 259
  • [27] Combination of bortezomib in the induction, conditioning and consolidation with autologous hematopoietic stem cell transplantation in patients with immunoglobulin light chain amyloidosis
    Huang, Xianghua
    Fu, Chengcheng
    Chen, Lijuan
    Chen, Wencui
    Ren, Guisheng
    Guo, Jinzhou
    Zhao, Liang
    Zeng, Caihong
    Zhang, Haitao
    Gong, Dehua
    Ren, Qiang
    Liu, Zhihong
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (04) : E101 - E104
  • [28] Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
    Sanchorawala, V
    Seldin, DC
    Magnani, B
    Skinner, M
    Wright, DG
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (07) : 597 - 600
  • [29] Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
    V Sanchorawala
    D C Seldin
    B Magnani
    M Skinner
    D G Wright
    [J]. Bone Marrow Transplantation, 2005, 36 : 597 - 600
  • [30] Evaluating the incidence of engraftment syndrome with different melphalan formulations in adult multiple myeloma and immunoglobulin light chain amyloidosis patients undergoing autologous hematopoietic cell transplantation
    Kowalski, Kaitlyn E.
    Wheeler, Sarah E.
    Adams, C. Brooke
    Voils, Stacy A.
    Richards, Ashley, I
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 274 - 281